Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized controlled trial. The aim of the study is to evaluate the
efficacy and safety of the Qingre Huashi Granules combined the modified dual therapy (or
called high dose dual therapy) for Helicobacter pylori infection specifically in geriatric
patients, compared with the bismuth containing quadruple therapy. A total of 160 eligible
patients will be enrolled in 4 hospitals. The eradication rate, symptoms, and the adverse
events will be recorded and analyzed.
Phase:
N/A
Details
Lead Sponsor:
Peking University First Hospital
Collaborators:
Beijing Changping Integrative Medicine Hospital Beijing Geriatric Hospital Peking University International Hospital